STOCK TITAN

Adicet Bio to Present at the Cantor Virtual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Adicet Bio (Nasdaq: ACET) announced that CEO Chen Schor will present at the Cantor Virtual Global Healthcare Conference on September 16, 2020, at 8:40 AM ET. A live audio webcast will be available on the company’s website, with a replay accessible for 30 days post-event.

The company specializes in developing allogeneic gamma delta T cell therapies for cancer and other diseases, enhancing immune responses with engineered T cells for better tumor targeting.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq:  ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer of Adicet Bio, will present at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 8:40 AM ET.

A live audio webcast of the presentation can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts:

Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com

 


FAQ

What is Adicet Bio's stock symbol?

Adicet Bio's stock symbol is ACET.

When will Chen Schor present at the Cantor Virtual Global Healthcare Conference?

Chen Schor will present on September 16, 2020, at 8:40 AM ET.

Where can I listen to the Adicet Bio presentation?

You can access the live audio webcast on Adicet Bio’s website in the Investors section.

What therapies does Adicet Bio develop?

Adicet Bio develops allogeneic gamma delta T cell therapies for cancer and other diseases.

How long will the presentation replay be available?

The archived replay will be available for 30 days after the presentation.

Adicet Bio, Inc.

NASDAQ:ACET

ACET Rankings

ACET Latest News

ACET Stock Data

77.45M
69.64M
1.59%
76.44%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON